COM:VOYAGERTHERAPEUTICS
Voyager Therapeutics
- Stock
Last Close
5.36
21/11 18:49
Market Cap
439.50M
Beta: -
Volume Today
260.30K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 17.33M - | 14.22M 17.96% | 10.13M 28.73% | 7.62M 24.82% | 104.39M 1,270.14% | 171.13M 63.93% | 37.41M 78.14% | 40.91M 9.33% | 250.01M 511.16% | ||
cost of revenue | 4.44M - | ||||||||||
gross profit | 17.33M - | 14.22M 17.96% | 10.13M 28.73% | 7.62M 24.82% | 104.39M 1,270.14% | 171.13M 63.93% | 37.41M 78.14% | 40.91M 9.33% | 245.57M 500.31% | ||
selling and marketing expenses | |||||||||||
general and administrative expenses | 5.47M - | 9.91M 81.18% | 13.27M 33.92% | 19.74M 48.74% | 33.81M 71.29% | 36.34M 7.47% | 34.99M 3.70% | 37.25M 6.44% | 30.98M 16.82% | 35.82M 15.63% | |
selling general and administrative expenses | 5.47M - | 9.91M 81.18% | 13.27M 33.92% | 19.74M 48.74% | 33.81M 71.29% | 36.34M 7.47% | 34.99M 3.70% | 37.25M 6.44% | 30.98M 16.82% | 35.82M 15.63% | |
research and development expenses | 8.90M - | 27.68M 211.07% | 42.25M 52.64% | 62.26M 47.36% | 64.91M 4.25% | 119.73M 84.48% | 108.75M 9.17% | 73.79M 32.15% | 60.76M 17.65% | 87.73M 44.38% | |
other expenses | -9.42M - | 1.16M 112.30% | 1.17M 0.60% | 2.63M 125.49% | 8.08M 207.65% | 7.70M 4.75% | 2.42M 68.55% | 4.45M 83.60% | 3K 99.93% | ||
cost and expenses | 14.37M - | 37.59M 161.63% | 55.52M 47.70% | 82.00M 47.69% | 98.71M 20.39% | 156.07M 58.10% | 143.74M 7.90% | 111.03M 22.76% | 91.74M 17.37% | 127.99M 39.51% | |
operating expenses | 14.37M - | 37.59M 161.63% | 55.52M 47.70% | 82.00M 47.69% | 98.71M 20.39% | 156.07M 58.10% | 143.74M 7.90% | 111.03M 22.76% | 91.74M 17.37% | 123.55M 34.67% | |
interest expense | 332K - | 976K 193.98% | -390K - | 1.79M 559.49% | |||||||
ebitda | -14.18M - | -20.25M 42.80% | -41.30M 103.91% | -71.86M 74.01% | -91.09M 26.76% | -51.68M 43.27% | 31.20M 160.37% | -73.62M 335.95% | -50.84M 30.94% | 126.45M 348.75% | |
operating income | -14.37M - | -20.25M 40.98% | -41.30M 103.91% | -71.86M 74.01% | -91.09M 26.76% | -51.68M 43.27% | 27.38M 152.99% | -73.62M 368.84% | -50.84M 30.94% | 122.01M 340.01% | |
depreciation and amortization | 184K - | 600K 226.09% | 612K 2% | 1.59M 160.62% | 2.12M 32.73% | 2.77M 30.61% | 3.82M 38.05% | 5.17M 35.32% | 6.19M 19.86% | 4.44M 28.27% | |
total other income expenses net | -1.95M - | -9.42M 382.97% | 1.16M 112.30% | 1.17M 0.60% | 2.63M 125.49% | 8.08M 207.65% | 9.36M 15.78% | 2.42M 74.13% | 4.45M 83.60% | 11.72M 163.76% | |
income before tax | -16.32M - | -29.67M 81.85% | -40.14M 35.28% | -70.70M 76.12% | -88.47M 25.14% | -43.60M 50.72% | 36.74M 184.27% | -71.20M 293.78% | -46.39M 34.84% | 133.74M 388.28% | |
income tax expense | -600K - | 52K 108.67% | -1.59M 3,167.31% | -180K 88.71% | -2.77M 1,436.11% | -1.66M 40% | -5.17M 211.33% | 16K 100.31% | 1.41M 8,700% | ||
net income | -16.32M - | -29.67M 81.85% | -40.19M 35.46% | -70.70M 75.90% | -88.29M 24.88% | -40.83M 53.75% | 36.74M 189.98% | -66.03M 279.72% | -46.41M 29.72% | 132.33M 385.14% | |
weighted average shs out | 14.71M - | 4.19M 71.51% | 25.30M 503.70% | 26.80M 5.93% | 32.07M 19.63% | 35.90M 11.95% | 37.13M 3.44% | 37.67M 1.44% | 38.36M 1.83% | 43.02M 12.16% | |
weighted average shs out dil | 14.71M - | 4.19M 71.51% | 25.30M 503.70% | 26.80M 5.93% | 32.07M 19.63% | 35.90M 11.95% | 37.35M 4.04% | 37.67M 0.86% | 38.36M 1.83% | 44.57M 16.20% | |
eps | -1.11 - | -7.08 537.84% | -1.59 77.54% | -2.64 66.04% | -2.75 4.17% | -1.14 58.55% | 0.99 186.84% | -1.75 276.77% | -1.21 30.86% | 3.08 354.55% | |
epsdiluted | -1.11 - | -7.08 537.84% | -1.59 77.54% | -2.64 66.04% | -2.75 4.17% | -1.14 58.55% | 0.98 185.96% | -1.75 278.57% | -1.21 30.86% | 2.97 345.45% |
All numbers in (except ratios and percentages)